Senator Raffy Tulfo criticized the Food and Drug Administration (FDA) for its negligence and inaction on the continued sale of unregistered products that pose health risks. During the Senate Committee on Finance hearing where the proposed 2026 budget of the Department of Health was tackled, Tulfo expressed his outrage over the ineffectiveness of FDA advisories. […]
